Max Healthcare Institute Limited
Max Healthcare Institute Limited Fundamental Analysis
Max Healthcare Institute Limited (MAXHEALTH.BO) shows moderate financial fundamentals with a PE ratio of 74.66, profit margin of 17.69%, and ROE of 15.09%. The company generates $80.2B in annual revenue with strong year-over-year growth of 30.01%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 69.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze MAXHEALTH.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakMAXHEALTH.BO struggles to generate sufficient returns from assets.
Valuation Score
WeakMAXHEALTH.BO trades at a premium to fair value.
Growth Score
ModerateMAXHEALTH.BO shows steady but slowing expansion.
Financial Health Score
ModerateMAXHEALTH.BO shows balanced financial health with some risks.
Profitability Score
ModerateMAXHEALTH.BO maintains healthy but balanced margins.
Key Financial Metrics
Is MAXHEALTH.BO Expensive or Cheap?
P/E Ratio
MAXHEALTH.BO trades at 74.66 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, MAXHEALTH.BO's PEG of 16.54 indicates potential overvaluation.
Price to Book
The market values Max Healthcare Institute Limited at 10.54 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 45.97 times EBITDA. This signals the market has high growth expectations.
How Well Does MAXHEALTH.BO Make Money?
Net Profit Margin
For every $100 in sales, Max Healthcare Institute Limited keeps $17.69 as profit after all expenses.
Operating Margin
Core operations generate 22.57 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $15.09 in profit for every $100 of shareholder equity.
ROA
Max Healthcare Institute Limited generates $8.72 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Max Healthcare Institute Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Max Healthcare Institute Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
MAXHEALTH.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
74.66
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
16.54
vs 25 benchmark
P/B Ratio
Price to book value ratio
10.54
vs 25 benchmark
P/S Ratio
Price to sales ratio
13.21
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.33
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.79
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.15
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.13
vs 25 benchmark
How MAXHEALTH.BO Stacks Against Its Sector Peers
| Metric | MAXHEALTH.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 74.66 | 29.45 | Worse (Expensive) |
| ROE | 15.09% | 779.00% | Weak |
| Net Margin | 17.69% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.33 | 0.26 | Weak (High Leverage) |
| Current Ratio | 0.79 | 4.65 | Weak Liquidity |
| ROA | 8.72% | -19344.00% (disorted) | Weak |
MAXHEALTH.BO outperforms its industry in 1 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Max Healthcare Institute Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
264.88%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
902.72%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
221.16%
Industry Style: Defensive, Growth, Innovation
High Growth